Tarbox Family Office’s Amphastar Pharmaceuticals AMPH Stock Holding History

Tarbox Family Office’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-168	Closed	-$6K	–	162
2022 Q1	$6K	Hold	168	–	–	﹤0.01%	459
2021 Q4	$4K	Buy	+168	New	+$3.44K	﹤0.01%	642
2021 Q2	–	Sell	-123	Closed	-$2K	–	1143
2021 Q1	$2K	Hold	123	–	–	﹤0.01%	837
2020 Q4	$2K	Hold	123	–	–	﹤0.01%	776
2020 Q3	$2K	Hold	123	–	–	﹤0.01%	711
2020 Q2	$3K	Hold	123	–	–	﹤0.01%	586
2020 Q1	$2K	Buy	+123	New	+$2.14K	﹤0.01%	598

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Tarbox Family Office's AMPH Position: Q2 2022 in Review

Tarbox Family Office sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2022, closing a stake of 168 shares — an estimated $6K sold.

Tarbox Family Office first reported a position in AMPH in Q1 2020 and held it in 7 quarters. The position peaked at $6K in Q1 2022. 223 funds tracked by Wall St. Rank hold AMPH as of Q2 2022.

Tarbox Family Office reported no remaining Amphastar Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 168 Amphastar Pharmaceuticals shares in Q2 2022, an estimated $6K.
Tarbox Family Office first reported a position in Amphastar Pharmaceuticals in Q1 2020 and held it in 7 quarters.
Tarbox Family Office's Amphastar Pharmaceuticals position peaked at $6K in Q1 2022.
223 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.